Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2005

Open Access 01-03-2005 | Research article

ANKHvariants associated with ankylosing spondylitis: gender differences

Authors: Hing Wo Tsui, Robert D Inman, Andrew D Paterson, John D Reveille, Florence WL Tsui

Published in: Arthritis Research & Therapy | Issue 3/2005

Login to get access

Abstract

The ank (progressive ankylosis) mutant mouse, which has a nonsense mutation in exon 12 of the inorganic pyrophosphate regulator gene (ank), exhibits aberrant joint ankylosis similar to human ankylosing spondylitis (AS). We previously performed family-based association analyses of 124 Caucasian AS families and showed that novel genetic markers in the 5' flanking region of ANKH (the human homolog of the murine ank gene) are modestly associated with AS. The objective of the present study was to conduct a more extensive evaluation of ANKH variants that are significantly associated with AS and to determine whether the association is gender specific. We genotyped 201 multiplex AS families with nine ANKH intragenetic and two flanking microsatellite markers, and performed family-based association analyses. We showed that ANKH variants located in two different regions of the ANKH gene were associated with AS. Results of haplotype analyses indicated that, after Bonferroni correction, the haplotype combination of rs26307 [C] and rs27356 [C] is significantly associated with AS in men (recessive/dominant model; P = 0.004), and the haplotype combination of rs28006 [C] and rs25957 [C] is significantly associated with AS in women (recessive/dominant model; P = 0.004). A test of interaction identified rs26307 (i.e. the region that was associated in men with AS) as showing a difference in the strength of the association by gender. The region associated with AS in women only showed significance in the test of interaction among the subset of families with affected individuals of both genders. These findings support the concept that ANKH plays a role in genetic susceptibility to AS and reveals a gender–genotype specificity in this interaction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Calin A: Ankylosing spondylitis. Oxford Textbook of Rheumatology. Edited by: Maddison PJ, Isenberg DA, Woo P, Glass DN. 1998, Oxford: Oxford University Press, 2: 1058-1070. Calin A: Ankylosing spondylitis. Oxford Textbook of Rheumatology. Edited by: Maddison PJ, Isenberg DA, Woo P, Glass DN. 1998, Oxford: Oxford University Press, 2: 1058-1070.
2.
go back to reference Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998, 41: 58-67. 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G.CrossRefPubMed Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998, 41: 58-67. 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G.CrossRefPubMed
3.
go back to reference Brown MA, Laval SH, Brophy S, Calin A: Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000, 59: 883-886. 10.1136/ard.59.11.883.PubMedCentralCrossRefPubMed Brown MA, Laval SH, Brophy S, Calin A: Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000, 59: 883-886. 10.1136/ard.59.11.883.PubMedCentralCrossRefPubMed
4.
go back to reference Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, Shatford JL, Weeks DE, Calin A, Wordsworth BP, et al: A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum. 1998, 41: 588-595. 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0.CrossRefPubMed Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, Shatford JL, Weeks DE, Calin A, Wordsworth BP, et al: A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum. 1998, 41: 588-595. 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0.CrossRefPubMed
5.
go back to reference Laval SH, Timms A, Edwards L, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A, et al: Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001, 68: 918-926. 10.1086/319509.PubMedCentralCrossRefPubMed Laval SH, Timms A, Edwards L, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A, et al: Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001, 68: 918-926. 10.1086/319509.PubMedCentralCrossRefPubMed
6.
go back to reference Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Kahn MA, Inman RD, Mahowald M, Maksymowych WP, Martin TM, et al: Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004, 50: 2246-2254. 10.1002/art.20308.CrossRefPubMed Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Kahn MA, Inman RD, Mahowald M, Maksymowych WP, Martin TM, et al: Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004, 50: 2246-2254. 10.1002/art.20308.CrossRefPubMed
7.
go back to reference Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000, 289: 265-270. 10.1126/science.289.5477.265.CrossRefPubMed Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000, 289: 265-270. 10.1126/science.289.5477.265.CrossRefPubMed
8.
go back to reference Tsui FWL, Tsui HW, Cheng EY, Stone M, Payne U, Reveille JD, Paterson AD, Inman RD: Novel genetic markers in the 5'-flanking region of ANKH are associated with ankylosing spondylitis. Arthritis Rheum. 2003, 48: 791-797. 10.1002/art.10844.CrossRefPubMed Tsui FWL, Tsui HW, Cheng EY, Stone M, Payne U, Reveille JD, Paterson AD, Inman RD: Novel genetic markers in the 5'-flanking region of ANKH are associated with ankylosing spondylitis. Arthritis Rheum. 2003, 48: 791-797. 10.1002/art.10844.CrossRefPubMed
9.
10.
go back to reference Eustace S, Coughlan RJ, McCarthy C: Ankylosing spondylitis. A comparison of clinical and radiographic features in men and women. Ir Med J. 1993, 86: 120-122.PubMed Eustace S, Coughlan RJ, McCarthy C: Ankylosing spondylitis. A comparison of clinical and radiographic features in men and women. Ir Med J. 1993, 86: 120-122.PubMed
11.
go back to reference Gran JT, Husby G, Hordvik M, Stormer J, Romberg-Andersen O: Radiological changes in men and women with ankylosing spondylitis. Ann Rheum Dis. 1984, 43: 570-575.PubMedCentralCrossRefPubMed Gran JT, Husby G, Hordvik M, Stormer J, Romberg-Andersen O: Radiological changes in men and women with ankylosing spondylitis. Ann Rheum Dis. 1984, 43: 570-575.PubMedCentralCrossRefPubMed
12.
go back to reference Will R, Edmunds L, Elswood J, Calin A: Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol. 1990, 17: 1649-1652.PubMed Will R, Edmunds L, Elswood J, Calin A: Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol. 1990, 17: 1649-1652.PubMed
13.
go back to reference Kidd B, Mullee M, Frank A, Cawley M: Disease expression of ankylosing spondylitis in males and females. J Rheumatol. 1988, 15: 1407-1409.PubMed Kidd B, Mullee M, Frank A, Cawley M: Disease expression of ankylosing spondylitis in males and females. J Rheumatol. 1988, 15: 1407-1409.PubMed
14.
go back to reference Guillemin F, Briancon S, Pourel J, Gaucher A: Longterm disability and prolonged sick leave as outcome measures in ankylosing spondylitis. Arthritis Rheum. 1990, 33: 1001-1006.CrossRefPubMed Guillemin F, Briancon S, Pourel J, Gaucher A: Longterm disability and prolonged sick leave as outcome measures in ankylosing spondylitis. Arthritis Rheum. 1990, 33: 1001-1006.CrossRefPubMed
15.
go back to reference Doran MF, Brophy S, MacKay K, Taylor G, Calin A: Predictors of longterm outcome in ankylosing spondylitis. J Rheum. 2003, 30: 316-320.PubMed Doran MF, Brophy S, MacKay K, Taylor G, Calin A: Predictors of longterm outcome in ankylosing spondylitis. J Rheum. 2003, 30: 316-320.PubMed
16.
go back to reference Hoyle E, Laval SH, Calin A, Wordsworth BP, Brown MA: The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum. 2000, 43: 1353-1355. 10.1002/1529-0131(200006)43:6<1353::AID-ANR19>3.0.CO;2-B.CrossRefPubMed Hoyle E, Laval SH, Calin A, Wordsworth BP, Brown MA: The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum. 2000, 43: 1353-1355. 10.1002/1529-0131(200006)43:6<1353::AID-ANR19>3.0.CO;2-B.CrossRefPubMed
17.
go back to reference Calin A, Brophy S, Blake D: Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet. 1999, 354: 1687-1690. 10.1016/S0140-6736(99)03219-5.CrossRefPubMed Calin A, Brophy S, Blake D: Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet. 1999, 354: 1687-1690. 10.1016/S0140-6736(99)03219-5.CrossRefPubMed
18.
go back to reference Brophy S, Taylor G, Blake D, Calin A: The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis and iritis. J Rheumatol. 2003, 30: 2054-2058.PubMed Brophy S, Taylor G, Blake D, Calin A: The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis and iritis. J Rheumatol. 2003, 30: 2054-2058.PubMed
19.
go back to reference Van der Linden S, Valkenburg H, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27: 361-368.CrossRefPubMed Van der Linden S, Valkenburg H, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27: 361-368.CrossRefPubMed
20.
go back to reference Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993, 52: 506-516.PubMedCentralPubMed Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993, 52: 506-516.PubMedCentralPubMed
21.
go back to reference Lake SL, Blacker D, Laird NM: Family-based tests of association in the presence of linkage. Am J Hum Genet. 1993, 52: 506-516. Lake SL, Blacker D, Laird NM: Family-based tests of association in the presence of linkage. Am J Hum Genet. 1993, 52: 506-516.
22.
go back to reference Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B: The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA. 2002, 99: 11890-11895. 10.1073/pnas.182376299.PubMedCentralCrossRefPubMed Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B: The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA. 2002, 99: 11890-11895. 10.1073/pnas.182376299.PubMedCentralCrossRefPubMed
23.
go back to reference DePrimo SE, Diehn M, Belson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD: Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 2002, 3: 32.1-32.12. 10.1186/gb-2002-3-7-research0032.CrossRef DePrimo SE, Diehn M, Belson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD: Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 2002, 3: 32.1-32.12. 10.1186/gb-2002-3-7-research0032.CrossRef
24.
go back to reference Segawa T, Nau ME, Xu LL, Chilukuri RN, Makaren M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, et al: Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene. 2002, 21: 8749-8758. 10.1038/sj.onc.1205992.CrossRefPubMed Segawa T, Nau ME, Xu LL, Chilukuri RN, Makaren M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, et al: Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene. 2002, 21: 8749-8758. 10.1038/sj.onc.1205992.CrossRefPubMed
25.
go back to reference The international HapMap Consortium: The international HapMap project. Nature. 2003, 426: 789-795. 10.1038/nature02168.CrossRef The international HapMap Consortium: The international HapMap project. Nature. 2003, 426: 789-795. 10.1038/nature02168.CrossRef
26.
go back to reference Paardt M, Dijkmans B, Giltay E, vander Horst-Bruinsma I: Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype. J Rheumatol. 2002, 29: 2583-2584.PubMed Paardt M, Dijkmans B, Giltay E, vander Horst-Bruinsma I: Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype. J Rheumatol. 2002, 29: 2583-2584.PubMed
27.
go back to reference Calin A, Kennedy LG, Edmunds L, Will R: Familial versus sporadic ankylosing spondylitis. Two different diseases?. Arthritis Rheum. 1993, 36: 676-681.CrossRefPubMed Calin A, Kennedy LG, Edmunds L, Will R: Familial versus sporadic ankylosing spondylitis. Two different diseases?. Arthritis Rheum. 1993, 36: 676-681.CrossRefPubMed
28.
go back to reference Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum. 1984, 27: 241-249.CrossRefPubMed Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum. 1984, 27: 241-249.CrossRefPubMed
29.
go back to reference Gran JT, Ostensen M, Husby G: A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol. 1985, 12: 126-129.PubMed Gran JT, Ostensen M, Husby G: A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol. 1985, 12: 126-129.PubMed
30.
go back to reference Feldtkeller E, Khan MA, van der Heijde Désirée, van der Linden S, Braun J: Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003, 23: 61-66.PubMed Feldtkeller E, Khan MA, van der Heijde Désirée, van der Linden S, Braun J: Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003, 23: 61-66.PubMed
31.
go back to reference Guo Y, Hsu DKW, Feng SY, Richards CM, Winkles JA: Polypeptide growth factors and phorbol ester induce progressive ankylosis (ank) gene expression in murine and human fibroblasts. J Cell Biochem. 2001, 84: 27-38. 10.1002/jcb.1263.CrossRefPubMed Guo Y, Hsu DKW, Feng SY, Richards CM, Winkles JA: Polypeptide growth factors and phorbol ester induce progressive ankylosis (ank) gene expression in murine and human fibroblasts. J Cell Biochem. 2001, 84: 27-38. 10.1002/jcb.1263.CrossRefPubMed
32.
go back to reference Timms AE, Zhang Y, Bradbury L, Wordsworth BP, Brown MA: Investigation of the role of ANKH in ankylosing spondylitis. Arthritis Rheum. 2003, 48: 2898-2902. 10.1002/art.11258.CrossRefPubMed Timms AE, Zhang Y, Bradbury L, Wordsworth BP, Brown MA: Investigation of the role of ANKH in ankylosing spondylitis. Arthritis Rheum. 2003, 48: 2898-2902. 10.1002/art.11258.CrossRefPubMed
Metadata
Title
ANKHvariants associated with ankylosing spondylitis: gender differences
Authors
Hing Wo Tsui
Robert D Inman
Andrew D Paterson
John D Reveille
Florence WL Tsui
Publication date
01-03-2005
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2005
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1701

Other articles of this Issue 3/2005

Arthritis Research & Therapy 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.